Credit: Florida Atlantic University
Jang-Yen (John) Wu, Ph.D., holds a bottle containing granulocyte colony-stimulating factor (GCSF). Data from the study support the hypothesis that GCSF is one of the few growth factors that can reduce infarction by decreasing endoplasmic reticulum (ER) and mitochondrial stress while improving behavioral performance in a mouse model.